Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates.

Zhang X, Newport GD, Callicott R, Liu S, Thompson J, Berridge MS, Apana SM, Slikker W Jr, Wang C, Paule MG.

Neurotoxicol Teratol. 2016 Jul-Aug;56:68-74. doi: 10.1016/j.ntt.2016.06.005. Epub 2016 Jun 12.

PMID:
27307090
2.

In Vivo Monitoring of Sevoflurane-induced Adverse Effects in Neonatal Nonhuman Primates Using Small-animal Positron Emission Tomography.

Zhang X, Liu S, Newport GD, Paule MG, Callicott R, Thompson J, Liu F, Patterson TA, Berridge MS, Apana SM, Brown CC, Maisha MP, Hanig JP, Slikker W Jr, Wang C.

Anesthesiology. 2016 Jul;125(1):133-46. doi: 10.1097/ALN.0000000000001154.

PMID:
27183169
3.

Positron Emission Tomography with [(18)F]FLT Revealed Sevoflurane-Induced Inhibition of Neural Progenitor Cell Expansion in vivo.

Liu S, Paule MG, Zhang X, Newport GD, Patterson TA, Apana SM, Berridge MS, Maisha MP, Slikker W Jr, Wang C.

Front Neurol. 2014 Nov 17;5:234. doi: 10.3389/fneur.2014.00234. eCollection 2014.

4.

Developmental toxicity assay using high content screening of zebrafish embryos.

Lantz-McPeak S, Guo X, Cuevas E, Dumas M, Newport GD, Ali SF, Paule MG, Kanungo J.

J Appl Toxicol. 2015 Mar;35(3):261-72. doi: 10.1002/jat.3029. Epub 2014 May 28.

5.

Effects of copper nanoparticles on rat cerebral microvessel endothelial cells.

Trickler WJ, Lantz SM, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Paule MG, Slikker W, Biris AS, Hussain SM, Ali SF.

Nanomedicine (Lond). 2012 Jun;7(6):835-46. doi: 10.2217/nnm.11.154. Epub 2012 Feb 16.

PMID:
22339089
6.

On the in vivo early toxic properties of A-beta 25-35 peptide in the rat hippocampus: involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression.

Cuevas E, Lantz SM, Tobón-Velasco JC, Newport GD, Wu Q, Virmani A, Ali SF, Santamaría A.

Neurotoxicol Teratol. 2011 Mar-Apr;33(2):288-96. doi: 10.1016/j.ntt.2010.12.002. Epub 2011 Jan 7.

PMID:
21216281
7.

Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability.

Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr, Hussain SM, Ali SF.

Nanotoxicology. 2011 Dec;5(4):479-92. doi: 10.3109/17435390.2010.540356. Epub 2010 Dec 22.

PMID:
21175299
8.

MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH.

Zhang X, Paule MG, Newport GD, Sadovova N, Berridge MS, Apana SM, Kabalka G, Miao W, Slikker W Jr, Wang C.

J Neural Transm (Vienna). 2011 Feb;118(2):203-11. doi: 10.1007/s00702-010-0499-z. Epub 2010 Oct 21.

PMID:
20963452
9.

Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells.

Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr, Hussain SM, Ali SF.

Toxicol Sci. 2010 Nov;118(1):160-70. doi: 10.1093/toxsci/kfq244. Epub 2010 Aug 16.

PMID:
20713472
10.

On the early toxic effect of quinolinic acid: involvement of RAGE.

Cuevas E, Lantz S, Newport G, Divine B, Wu Q, Paule MG, Tobón-Velasco JC, Ali SF, Santamaría A.

Neurosci Lett. 2010 Apr 26;474(2):74-8. doi: 10.1016/j.neulet.2010.03.007. Epub 2010 Mar 17.

PMID:
20223279
11.

Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles.

Wang J, Rahman MF, Duhart HM, Newport GD, Patterson TA, Murdock RC, Hussain SM, Schlager JJ, Ali SF.

Neurotoxicology. 2009 Nov;30(6):926-33. doi: 10.1016/j.neuro.2009.09.005. Epub 2009 Sep 23.

PMID:
19781568
12.

A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V.

Zhang X, Paule MG, Newport GD, Zou X, Sadovova N, Berridge MS, Apana SM, Hanig JP, Slikker W Jr, Wang C.

Toxicol Sci. 2009 Oct;111(2):355-61. doi: 10.1093/toxsci/kfp167. Epub 2009 Jul 28.

PMID:
19638431
13.

Acrylamide decreased dopamine levels and increased 3-nitrotyrosine (3-NT) levels in PC 12 cells.

Tareke E, Lyn-Cook BD, Duhart H, Newport G, Ali S.

Neurosci Lett. 2009 Jul 17;458(2):89-92. doi: 10.1016/j.neulet.2009.04.016. Epub 2009 Apr 11.

PMID:
19442880
14.

Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles.

Rahman MF, Wang J, Patterson TA, Saini UT, Robinson BL, Newport GD, Murdock RC, Schlager JJ, Hussain SM, Ali SF.

Toxicol Lett. 2009 May 22;187(1):15-21. doi: 10.1016/j.toxlet.2009.01.020. Epub 2009 Jan 23.

PMID:
19429238
15.

Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.

Wang J, Duhart HM, Xu Z, Patterson TA, Newport GD, Ali SF.

Neurochem Int. 2008 May;52(6):1037-43. Epub 2007 Nov 4.

PMID:
18069091
16.

How do they do it? Insight on calendar skills from an Asperger's savant.

Newport G.

J Autism Dev Disord. 2006 Feb;36(2):285-6. No abstract available.

PMID:
16612577
17.

Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans.

Murillo LA, Newport G, Lan CY, Habelitz S, Dungan J, Agabian NM.

Eukaryot Cell. 2005 Sep;4(9):1562-73.

18.

Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells.

Xu Z, Cawthon D, McCastlain KA, Duhart HM, Newport GD, Fang H, Patterson TA, Slikker W Jr, Ali SF.

Neurotoxicology. 2005 Aug;26(4):729-37.

PMID:
16112330
19.

A human-curated annotation of the Candida albicans genome.

Braun BR, van Het Hoog M, d'Enfert C, Martchenko M, Dungan J, Kuo A, Inglis DO, Uhl MA, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro CA, Bates S, Gow NA, Hoyer LL, Köhler G, Morschhäuser J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell AP, Johnson AD, Whiteway M, Nantel A.

PLoS Genet. 2005 Jul;1(1):36-57. Epub 2005 Jun 17.

20.

Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry.

Hardt M, Thomas LR, Dixon SE, Newport G, Agabian N, Prakobphol A, Hall SC, Witkowska HE, Fisher SJ.

Biochemistry. 2005 Mar 1;44(8):2885-99.

PMID:
15723531
21.

Regulatory networks affected by iron availability in Candida albicans.

Lan CY, Rodarte G, Murillo LA, Jones T, Davis RW, Dungan J, Newport G, Agabian N.

Mol Microbiol. 2004 Sep;53(5):1451-69.

22.

A 63 kDa VSP9B10A-like protein expressed in a C-8 Giardia duodenalis Mexican clone.

Bermúdez-Cruz RM, Ortega-Pierres G, Ceja V, Coral-Vázquez R, Fonseca R, Cervantes L, Sánchez A, Depardón F, Newport G, Montañéz C.

Arch Med Res. 2004 May-Jun;35(3):199-208.

PMID:
15163460
23.

The diploid genome sequence of Candida albicans.

Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, Magee BB, Newport G, Thorstenson YR, Agabian N, Magee PT, Davis RW, Scherer S.

Proc Natl Acad Sci U S A. 2004 May 11;101(19):7329-34. Epub 2004 May 3.

24.

Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations.

Bowyer JF, Young JF, Slikker W, Itzak Y, Mayorga AJ, Newport GD, Ali SF, Frederick DL, Paule MG.

Neurotoxicology. 2003 Jun;24(3):379-90.

PMID:
12782103
25.

Inactivation of Kex2p diminishes the virulence of Candida albicans.

Newport G, Kuo A, Flattery A, Gill C, Blake JJ, Kurtz MB, Abruzzo GK, Agabian N.

J Biol Chem. 2003 Jan 17;278(3):1713-20. Epub 2002 Nov 4.

26.

Metabolic specialization associated with phenotypic switching in Candidaalbicans.

Lan CY, Newport G, Murillo LA, Jones T, Scherer S, Davis RW, Agabian N.

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14907-12. Epub 2002 Oct 23.

27.

Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine.

Pereira FC, Imam SZ, Gough B, Newport GD, Ribeiro CF, Slikker W Jr, Macedo TR, Ali SF.

J Neural Transm (Vienna). 2002 Sep;109(9):1151-8.

PMID:
12203042
28.
29.

Assessing the potential toxicity of MK-801 and remacemide: chronic exposure in juvenile rhesus monkeys.

Popke EJ, Patton R, Newport GD, Rushing LG, Fogle CM, Allen RR, Pearson EC, Hammond TG, Paule MG.

Neurotoxicol Teratol. 2002 Mar-Apr;24(2):193-207.

PMID:
11943507
30.

Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts.

Imam SZ, el-Yazal J, Newport GD, Itzhak Y, Cadet JL, Slikker W Jr, Ali SF.

Ann N Y Acad Sci. 2001 Jun;939:366-80. Review.

PMID:
11462792
31.

In favour of retaining anaesthetic induction rooms.

Newport GA.

Anaesthesia. 2001 Jul;56(7):691. No abstract available.

33.

Transplacental pharmacokinetics and fetal distribution of 2', 3'-didehydro-3'-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques.

Patterson TA, Binienda ZK, Newport GD, Lipe GW, Gillam MP, Slikker W Jr, Sandberg JA.

Teratology. 2000 Aug;62(2):93-9.

PMID:
10931506
34.

An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate.

Bowyer JF, Newport GD, Slikker W Jr, Gough B, Ferguson SA, Tor-Agbidye J.

Toxicol Sci. 2000 May;55(1):133-42.

PMID:
10788568
35.

Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst.

Imam SZ, Crow JP, Newport GD, Islam F, Slikker W Jr, Ali SF.

Brain Res. 1999 Aug 7;837(1-2):15-21.

PMID:
10433983
36.

In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.

Naglik JR, Newport G, White TC, Fernandes-Naglik LL, Greenspan JS, Greenspan D, Sweet SP, Challacombe SJ, Agabian N.

Infect Immun. 1999 May;67(5):2482-90.

37.

Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice.

Yu X, Imam SZ, Newport GD, Slikker W Jr, Ali SF.

Brain Res. 1999 Mar 27;823(1-2):213-6.

PMID:
10095030
38.

Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity.

Imam SZ, Newport GD, Islam F, Slikker W Jr, Ali SF.

Brain Res. 1999 Feb 13;818(2):575-8.

PMID:
10082851
39.

Effect of manganese on the concentration of amino acids in different regions of the rat brain.

Lipe GW, Duhart H, Newport GD, Slikker W Jr, Ali SF.

J Environ Sci Health B. 1999 Jan;34(1):119-32.

PMID:
10048208
40.
41.

Cloning and regulated expression of the Candida albicans phospholipase B (PLB1) gene.

Hoover CI, Jantapour MJ, Newport G, Agabian N, Fisher SJ.

FEMS Microbiol Lett. 1998 Oct 15;167(2):163-9.

43.

KEX2 influences Candida albicans proteinase secretion and hyphal formation.

Newport G, Agabian N.

J Biol Chem. 1997 Nov 14;272(46):28954-61.

45.

Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents.

Ali SF, Newport GD, Slikker W Jr.

Ann N Y Acad Sci. 1996 Oct 31;801:187-98.

PMID:
8959033
46.

Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation.

Ali SF, Newport GD, Slikker W Jr, Rothman RB, Baumann MH.

Brain Res. 1996 Oct 21;737(1-2):215-20.

PMID:
8930368
47.

Individual differences in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putamen in unlesioned rats.

Clausing P, Bloom D, Newport GD, Holson RR, Slikker W Jr, Bowyer JF.

Psychopharmacology (Berl). 1996 Oct;127(3):187-94.

PMID:
8912396
48.

Central and peripheral neurochemical alterations and immune effects of prenatal ethanol exposure in rats.

Clausing P, Ali SF, Taylor LD, Newport GD, Rybak S, Paule MG.

Int J Dev Neurosci. 1996 Jul;14(4):461-9.

PMID:
8884379
49.

Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum.

Bowyer JF, Clausing P, Schmued L, Davies DL, Binienda Z, Newport GD, Scallet AC, Slikker W Jr.

Brain Res. 1996 Mar 18;712(2):221-9.

PMID:
8814896
50.

Manganese-induced reactive oxygen species: comparison between Mn+2 and Mn+3.

Ali SF, Duhart HM, Newport GD, Lipe GW, Slikker W Jr.

Neurodegeneration. 1995 Sep;4(3):329-34.

PMID:
8581566

Supplemental Content

Loading ...
Support Center